Results
1 -
4 of
4Improvement of Renal Function with Selective Thromboxane A2 Synthetase Inhibitor, DP-1904 in Lupus Nephritis, Recent Advances in Prostaglandin, Thromboxane, and Leukotriene Research Pharmacokinetic-pharmacodynamic modelling of DP-1904, a novel thromboxane synthetase inhibitor in rabbits, based on an indirect response model, European Journal of Drug Metabolism and Pharmacokinetics The dehydration behavior of nafagrel hydrochloride hydrates, Journal of Thermal Analysis A Novel Thromboxane Synthetase Inhibitor, Dp-1904, Inhibits Human Blood Eosinophil Degranulation, Inflammation